 |
 |
 |
 |
|
 |
Treatment |
 |
Location |
 |
Last Updated |
 |
 |
 |
Details |
 |
Phase II Clinical Trial of Hyperbaric Oxygenation in Conjunction with Radiotherapy and Temozolomide in Adults with Newly Diagnosed Glioblastoma |
 |
Mineola, NY USA |
 |
06/18/2009 |
 |
 |
 |
 |
 |
Details |
 |
Radiation Therapy and Stereotactic Radiosurgery With or Without Temozolomide or Erlotinib in Treating Patients With Brain Metastases Secondary to Non-Small Cell Lung Cancer |
 |
Oceanside, NY USA |
 |
05/20/2009 |
 |
 |
 |
Details |
 |
A Phase II Clinical Trial of the Histone Deacetylase Inhibitor Valproic Acid in Combination With Temodar and Radiation Therapy in Patients With High Grade Gliomas
|
 |
Bethesda, MD USA |
 |
04/21/2009 |
 |
 |
 |
 |
 |
Details |
 |
Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) |
 |
Cincinnati, OH USA |
 |
04/06/2009 |
 |
 |
 |
Details |
 |
Study of a Drug [DCVax®-Brain] to Treat Newly Diagnosed GBM Brain Cancer |
 |
Cincinnati, OH USA |
 |
04/06/2009 |
 |
 |
 |
 |
 |
Details |
 |
RTOG 0424 A Phase II Study of Temozolomide-Based Chemoradiotherapy Regimen for High Risk Low-Grade Gliomas |
 |
Cincinnati, OH USA |
 |
04/06/2009 |
 |
 |
 |
Details |
 |
A Multicenter Prospective Analysis of Treatment Outcomes in Patients with Large Acoustic Neuromas Receiving Subtotal Resection with Back up Stereotactic Radiation Therapy |
 |
Cincinnati, OH USA |
 |
04/06/2009 |
 |
 |
 |
 |
 |
Details |
 |
Phase I/II study of sorafenib with radiation and temozolomide in newly diagnosed glioblastoma or gliosarcoma |
 |
Houston, TX USA |
 |
04/03/2009 |
 |
 |
 |
Details |
 |
Study of a Drug [DCVax®-Brain] to Treat Newly Diagnosed GBM Brain Cancer |
 |
Dallas, TX USA |
 |
03/15/2009 |
 |
 |
 |
 |
 |
Details |
 |
Study of a Drug [DCVax®-Brain] to Treat Newly Diagnosed GBM Brain Cancer |
 |
Tampa, FL USA |
 |
03/15/2009 |
 |
 |
 |
Details |
 |
Study of a Drug [DCVax®-Brain] to Treat Newly Diagnosed GBM Brain Cancer |
 |
Summit, NJ USA |
 |
03/15/2009 |
 |
 |
 |
 |
 |
Details |
 |
Study of a Drug [DCVax®-Brain] to Treat Newly Diagnosed GBM Brain Cancer |
 |
Cleveland, OH USA |
 |
03/15/2009 |
 |
 |
 |
Details |
 |
Study of a Drug [DCVax®-Brain] to Treat Newly Diagnosed GBM Brain Cancer |
 |
Los Angeles, CA USA |
 |
03/15/2009 |
 |
 |
 |
 |
 |
Details |
 |
Study of a Drug [DCVax®-Brain] to Treat Newly Diagnosed GBM Brain Cancer |
 |
Columbus, OH USA |
 |
03/15/2009 |
 |
 |
 |
Details |
 |
Study of a Drug [DCVax®-Brain] to Treat Newly Diagnosed GBM Brain Cancer |
 |
Chicago, IL USA |
 |
03/15/2009 |
 |
 |
 |
 |
 |
Details |
 |
Study of a Drug [DCVax®-Brain] to Treat Newly Diagnosed GBM Brain Cancer |
 |
Ann Arbor, MI USA |
 |
03/15/2009 |
 |
 |
 |
Details |
 |
Study of a Drug [DCVax®-Brain] to Treat Newly Diagnosed GBM Brain Cancer |
 |
Minneapolis, MN USA |
 |
03/15/2009 |
 |
 |
 |
 |
 |
Details |
 |
Study of a Drug [DCVax®-Brain] to Treat Newly Diagnosed GBM Brain Cancer |
 |
Rochester, NY USA |
 |
03/15/2009 |
 |
 |
 |
Details |
 |
The GLASS-ART Trial: A Phase III Randomized Study of Neuradiab in Combination With External Beam Radiation and Temozolomide Versus External Beam Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme |
 |
Durham, NC USA |
 |
03/04/2009 |
 |
 |
 |
 |
 |
Details |
 |
The GLASS-ART Trial: A Phase III Randomized Study of Neuradiab in Combination With External Beam Radiation and Temozolomide Versus External Beam Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme |
 |
New York, NY USA |
 |
03/04/2009 |
 |
 |
 |
Details |
 |
The GLASS-ART Trial: A Phase III Randomized Study of Neuradiab in Combination With External Beam Radiation and Temozolomide Versus External Beam Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme |
 |
Tampa, FL USA |
 |
03/04/2009 |
 |
 |
 |
 |
 |
Details |
 |
The GLASS-ART Trial: A Phase III Randomized Study of Neuradiab in Combination With External Beam Radiation and Temozolomide Versus External Beam Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme |
 |
Los Angeles, CA USA |
 |
03/04/2009 |
 |
 |
 |
Details |
 |
The GLASS-ART Trial: A Phase III Randomized Study of Neuradiab in Combination With External Beam Radiation and Temozolomide Versus External Beam Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme |
 |
Omaha, NE USA |
 |
03/04/2009 |
 |
 |
 |
 |
 |
Details |
 |
Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) |
 |
Chicago, IL USA |
 |
01/31/2009 |
 |
 |
 |
Details |
 |
Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) |
 |
Detroit, MI USA |
 |
01/31/2009 |
 |
 |
 |
 |
 |
Details |
 |
Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) |
 |
Los Angeles, CA USA |
 |
01/31/2009 |
 |
 |
 |
Details |
 |
Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) |
 |
Durham, NC USA |
 |
01/31/2009 |
 |
 |
 |
 |
 |
Details |
 |
Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) |
 |
San Francisco, CA USA |
 |
01/31/2009 |
 |
 |
 |
Details |
 |
Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) |
 |
Charlottesville, VA USA |
 |
01/31/2009 |
 |
 |
 |
 |
 |
Details |
 |
Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) |
 |
Cleveland, OH USA |
 |
01/31/2009 |
 |
 |
 |
Details |
 |
Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) |
 |
Cleveland, OH USA |
 |
01/31/2009 |
 |
 |
 |
 |
 |
Details |
 |
Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) |
 |
Hackensack, NJ USA |
 |
01/31/2009 |
 |
 |
 |
Details |
 |
Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) |
 |
Syracuse, NY USA |
 |
01/31/2009 |
 |
 |
 |
 |
 |
Details |
 |
Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) |
 |
Chicago, IL USA |
 |
01/31/2009 |
 |
 |
 |
Details |
 |
Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) |
 |
Los Angeles, CA USA |
 |
01/31/2009 |
 |
 |
 |
 |
 |
Details |
 |
Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) |
 |
Boston, MA |
 |
01/31/2009 |
 |
 |
 |
Details |
 |
Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) |
 |
Jacksonville, FL USA |
 |
01/31/2009 |
 |
 |
 |
 |
 |
Details |
 |
Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) |
 |
New Haven, CT USA |
 |
01/31/2009 |
 |
 |
 |
Details |
 |
Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) |
 |
Buffalo, NY USA |
 |
01/31/2009 |
 |
 |
 |
 |
 |
Details |
 |
Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) |
 |
Salt Lake City, UT USA |
 |
01/31/2009 |
 |
 |
 |
Details |
 |
Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) |
 |
Columbus, OH USA |
 |
01/31/2009 |
 |
 |
 |
 |
 |
Details |
 |
Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) |
 |
Evanston, IL USA |
 |
01/31/2009 |
 |
 |
 |
Details |
 |
Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) |
 |
New York, NY USA |
 |
01/31/2009 |
 |
 |
 |
 |
 |
Details |
 |
Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) |
 |
Palo Alto, CA USA |
 |
01/31/2009 |
 |
 |
 |
Details |
 |
Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) |
 |
New York, NY USA |
 |
01/31/2009 |
 |
 |
 |
 |
 |
Details |
 |
Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) |
 |
Philadelphia, PA USA |
 |
01/31/2009 |
 |
 |
 |
Details |
 |
Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) |
 |
Houston, TX USA |
 |
01/31/2009 |
 |
 |
 |
 |
 |
Details |
 |
Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) |
 |
Iowa City, IA USA |
 |
01/31/2009 |
 |
 |
 |
Details |
 |
Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) |
 |
Seattle, WA USA |
 |
01/31/2009 |
 |
 |
 |
 |
 |
Details |
 |
Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) |
 |
New York, NY USA |
 |
01/31/2009 |
 |
 |
 |
Details |
 |
Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) |
 |
San Francisco, CA USA |
 |
01/31/2009 |
 |
 |
 |
 |
 |
Details |
 |
Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) |
 |
Saginaw, MI USA |
 |
01/31/2009 |
 |
 |
 |
Details |
 |
Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) |
 |
Gainsville, FL USA |
 |
01/31/2009 |
 |
 |
 |
 |
 |
Details |
 |
Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) |
 |
San Antonio, TX USA |
 |
01/31/2009 |
 |
 |
 |
Details |
 |
Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) |
 |
Orange, CA USA |
 |
01/31/2009 |
 |
 |
 |
 |
 |
Details |
 |
Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) |
 |
Atlanta, GA USA |
 |
01/31/2009 |
 |
 |
 |
Details |
 |
Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) |
 |
Baltimore, MD USA |
 |
01/31/2009 |
 |
 |
 |
 |
 |
Details |
 |
Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) |
 |
Lansing, MI USA |
 |
01/31/2009 |
 |
 |
 |
Details |
 |
Erlotinib and Temozolomide With Radiation Therapy in Treating Patients With Glioblastoma Multiforme or Other Brain Tumors |
 |
Charlottesville, VA USA |
 |
09/30/2008 |
 |
 |
 |
 |
 |
Details |
 |
Phase I/II Study of ZD6474 (ZactimaTM) With Radiation Therapy and Concomitant and Adjuvant Temozolomide in Patients With Newly-Diagnosed Glioblastoma |
 |
Charlottesville, VA USA |
 |
09/30/2008 |
 |
 |
 |
Details |
 |
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
 |
Tampa, FL USA |
 |
04/11/2008 |
 |
 |
 |
 |
 |
Details |
 |
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
 |
Akron, OH USA |
 |
04/11/2008 |
 |
 |
 |
Details |
 |
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
 |
Cleveland, OH |
 |
04/11/2008 |
 |
 |
 |
 |
 |
Details |
 |
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
 |
Springfield, MO USA |
 |
04/11/2008 |
 |
 |
 |
Details |
 |
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
 |
Goldsboro, NC USA |
 |
04/11/2008 |
 |
 |
 |
 |
 |
Details |
 |
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
 |
, OH USA |
 |
04/11/2008 |
 |
 |
 |
Details |
 |
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
 |
Greenville, SC USA |
 |
04/11/2008 |
 |
 |
 |
 |
 |
Details |
 |
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
 |
Akron, OH USA |
 |
04/11/2008 |
 |
 |
 |
Details |
 |
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
 |
Wynnewood, PA USA |
 |
04/11/2008 |
 |
 |
 |
 |
 |
Details |
 |
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
 |
Kingsport, TN USA |
 |
04/11/2008 |
 |
 |
 |
Details |
 |
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
 |
Newark, DE USA |
 |
04/11/2008 |
 |
 |
 |
 |
 |
Details |
 |
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
 |
Philadelphia, PA USA |
 |
04/11/2008 |
 |
 |
 |
Details |
 |
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
 |
Mobile, AL USA |
 |
04/11/2008 |
 |
 |
 |
 |
 |
Details |
 |
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
 |
Loma Linda, CA USA |
 |
04/11/2008 |
 |
 |
 |
Details |
 |
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
 |
Sacramento, CA USA |
 |
04/11/2008 |
 |
 |
 |
 |
 |
Details |
 |
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
 |
Pomona, CA USA |
 |
04/11/2008 |
 |
 |
 |
Details |
 |
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
 |
Sacramento, CA USA |
 |
04/11/2008 |
 |
 |
 |
 |
 |
Details |
 |
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
 |
Lewes, DE USA |
 |
04/11/2008 |
 |
 |
 |
Details |
 |
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
 |
Newark, DE USA |
 |
04/11/2008 |
 |
 |
 |
 |
 |
Details |
 |
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
 |
Jacksonville, FL USA |
 |
04/11/2008 |
 |
 |
 |
Details |
 |
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
 |
Columbus, GA USA |
 |
04/11/2008 |
 |
 |
 |
 |
 |
Details |
 |
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
 |
Honolula, HI USA |
 |
04/11/2008 |
 |
 |
 |
Details |
 |
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
 |
Boise, ID USA |
 |
04/11/2008 |
 |
 |
 |
 |
 |
Details |
 |
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
 |
Maywood, IL USA |
 |
04/11/2008 |
 |
 |
 |
Details |
 |
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
 |
Harvey, IL USA |
 |
04/11/2008 |
 |
 |
 |
 |
 |
Details |
 |
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
 |
Chicago, IL USA |
 |
04/11/2008 |
 |
 |
 |
Details |
 |
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
 |
South Bend,, IN USA |
 |
04/11/2008 |
 |
 |
 |
 |
 |
Details |
 |
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
 |
South Bend, IN USA |
 |
04/11/2008 |
 |
 |
 |
Details |
 |
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
 |
Annapolis, MD USA |
 |
04/11/2008 |
 |
 |
 |
 |
 |
Details |
 |
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
 |
Detroit, MI USA |
 |
04/11/2008 |
 |
 |
 |
Details |
 |
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
 |
Royal Oak, MI USA |
 |
04/11/2008 |
 |
 |
 |
 |
 |
Details |
 |
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
 |
Saint Louis Park, MN USA |
 |
04/11/2008 |
 |
 |
 |
Details |
 |
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
 |
Edina, MN USA |
 |
04/11/2008 |
 |
 |
 |
 |
 |
Details |
 |
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
 |
Robbinsdale, MN USA |
 |
04/11/2008 |
 |
 |
 |
Details |
 |
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
 |
Minneapolis, MN USA |
 |
04/11/2008 |
 |
 |
 |
 |
 |
Details |
 |
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
 |
Cape Girardeau, MO USA |
 |
04/11/2008 |
 |
 |
 |
Details |
 |
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
 |
Kansas City, MO USA |
 |
04/11/2008 |
 |
 |
 |
 |
 |
Details |
 |
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
 |
Saint Louis, MO USA |
 |
04/11/2008 |
 |
 |
 |
Details |
 |
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
 |
St Louis, MO USA |
 |
04/11/2008 |
 |
 |
 |
 |
 |
Details |
 |
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
 |
Joplin, MO USA |
 |
04/11/2008 |
 |
 |
 |
Details |
 |
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
 |
Omaha, NE USA |
 |
04/11/2008 |
 |
 |
 |
 |
 |
Details |
 |
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
 |
Concord, NH USA |
 |
04/11/2008 |
 |
 |
 |
Details |
 |
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
 |
Lebanon, NH USA |
 |
04/11/2008 |
 |
 |
 |
 |
 |
Details |
 |
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
 |
Voorhees, NJ USA |
 |
04/11/2008 |
 |
 |
 |
Details |
 |
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
 |
Marlton, NJ USA |
 |
04/11/2008 |
 |
 |
 |
 |
 |
Details |
 |
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
 |
Toms River, NJ USA |
 |
04/11/2008 |
 |
 |
 |
Details |
 |
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
 |
Long Branch,, NJ USA |
 |
04/11/2008 |
 |
 |
 |
 |
 |
Details |
 |
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
 |
Syracuse, NY USA |
 |
04/11/2008 |
 |
 |
 |
Details |
 |
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
 |
Rochester, NY USA |
 |
04/11/2008 |
 |
 |
 |
 |
 |
Details |
 |
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
 |
Minot, ND USA |
 |
04/11/2008 |
 |
 |
 |
Details |
 |
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
 |
Chillicothe, OH USA |
 |
04/11/2008 |
 |
 |
 |
 |
 |
Details |
 |
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
 |
Akron, OH USA |
 |
04/11/2008 |
 |
 |
 |
Details |
 |
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
 |
Canton, OH USA |
 |
04/11/2008 |
 |
 |
 |
 |
 |
Details |
 |
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
 |
Wooster, OH USA |
 |
04/11/2008 |
 |
 |
 |
Details |
 |
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
 |
Columbus, OH USA |
 |
04/11/2008 |
 |
 |
 |
 |
 |
Details |
 |
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
 |
Zanesville, OH USA |
 |
04/11/2008 |
 |
 |
 |
Details |
 |
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
 |
Columbus, OH USA |
 |
04/11/2008 |
 |
 |
 |
 |
 |
Details |
 |
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
 |
Columbus, OH USA |
 |
04/11/2008 |
 |
 |
 |
Details |
 |
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
 |
Tulsa, OK USA |
 |
04/11/2008 |
 |
 |
 |
 |
 |
Details |
 |
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
 |
Bryn Mawr, PA USA |
 |
04/11/2008 |
 |
 |
 |
Details |
 |
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
 |
Philadelphia, PA USA |
 |
04/11/2008 |
 |
 |
 |
 |
 |
Details |
 |
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
 |
Philadelphia, PA USA |
 |
04/11/2008 |
 |
 |
 |
Details |
 |
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
 |
Allentown, PA USA |
 |
04/11/2008 |
 |
 |
 |
 |
 |
Details |
 |
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
 |
Paoli, PA USA |
 |
04/11/2008 |
 |
 |
 |
Details |
 |
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
 |
Reading, PA USA |
 |
04/11/2008 |
 |
 |
 |
 |
 |
Details |
 |
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
 |
Bethlehem, PA USA |
 |
04/11/2008 |
 |
 |
 |
Details |
 |
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
 |
Greenville, SC USA |
 |
04/11/2008 |
 |
 |
 |
 |
 |
Details |
 |
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
 |
Charleston, SC USA |
 |
04/11/2008 |
 |
 |
 |
Details |
 |
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
 |
Rapid City, SD USA |
 |
04/11/2008 |
 |
 |
 |
 |
 |
Details |
 |
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
 |
Kingsport, TN USA |
 |
04/11/2008 |
 |
 |
 |
Details |
 |
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
 |
Temple, TX USA |
 |
04/11/2008 |
 |
 |
 |
 |
 |
Details |
 |
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
 |
Lubbock, TX USA |
 |
04/11/2008 |
 |
 |
 |
Details |
 |
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
 |
Galveston, TX USA |
 |
04/11/2008 |
 |
 |
 |
 |
 |
Details |
 |
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
 |
Murray, UT USA |
 |
04/11/2008 |
 |
 |
 |
Details |
 |
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
 |
Saint George, UT USA |
 |
04/11/2008 |
 |
 |
 |
 |
 |
Details |
 |
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
 |
Salt Lake City, UT USA |
 |
04/11/2008 |
 |
 |
 |
Details |
 |
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
 |
Ogden, UT USA |
 |
04/11/2008 |
 |
 |
 |
 |
 |
Details |
 |
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
 |
Provo, UT USA |
 |
04/11/2008 |
 |
 |
 |
Details |
 |
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
 |
Burlington, VT USA |
 |
04/11/2008 |
 |
 |
 |
 |
 |
Details |
 |
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
 |
Yakima, WA USA |
 |
04/11/2008 |
 |
 |
 |
Details |
 |
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
 |
Bellingham, WA USA |
 |
04/11/2008 |
 |
 |
 |
 |
 |
Details |
 |
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
 |
Racine, WI USA |
 |
04/11/2008 |
 |
 |
 |
Details |
 |
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
 |
Menomonee Falls, WI USA |
 |
04/11/2008 |
 |
 |
 |
 |
 |
Details |
 |
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
 |
La Crosse, WI USA |
 |
04/11/2008 |
 |
 |
 |
Details |
 |
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
 |
Milwaukee, WI USA |
 |
04/11/2008 |
 |
 |
 |
 |
 |
Details |
 |
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
 |
Green Bay, WI USA |
 |
04/11/2008 |
 |
 |
 |
Details |
 |
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
 |
Madison, WI USA |
 |
04/11/2008 |
 |
 |
 |
 |
 |
Details |
 |
Chemotherapy, Radiation Therapy, and Vaccine Therapy With or Without Daclizumab in Treating Patients With Glioblastoma Multiforme That Has Been Removed by Surgery |
 |
Durham, NC USA |
 |
03/02/2008 |
 |
 |
 |
Details |
 |
A Pharmacokinetic and Pharmacogenomic Study of Patients With High-Grade Gliomas Receiving Daily Radiation Therapy and Temozolomide |
 |
Baltimore, MD USA |
 |
08/31/2007 |
 |
 |
 |
 |
 |
Details |
 |
A Pharmacokinetic and Pharmacogenomic Study of Patients With High-Grade Gliomas Receiving Daily Radiation Therapy and Temozolomide |
 |
Duarte, CA USA |
 |
08/31/2007 |
 |
 |
 |
Details |
 |
A Randomized Phase III Study of Temozolomide and Short-Course Radiation Versus Short-Course Radiation Alone In The Treatment of Newly Diagnosed Glioblastoma Multiforme in Elderly Patients |
 |
Toronto, Ontario, CANADA |
 |
08/26/2007 |
 |
 |
 |
 |
 |
Details |
 |
The Effect of Radiotherapy and Temozolomide on the Tumor Vasculature and Stem Cells in Human High-Grade Astrocytomas |
 |
Bergen, Norway |
 |
08/26/2007 |
 |
 |
 |
Details |
 |
Phase I/II Study of Fractionated CyberKnife Stereotactic Radiosurgery for High Grade Gliomas in Elderly Patients With Poor Performance Status |
 |
Boston, MA USA |
 |
08/26/2007 |
 |
 |
 |
 |
 |
Details |
 |
Open-Label Dose Confirmation and Dosimetry Study of Interstitial 131I-chTNT-1/B mAb (Cotara®) for the Treatment of Recurrent Glioblastoma Multiforme |
 |
Philadelphia, PA USA |
 |
08/26/2007 |
 |
 |
 |
Details |
 |
Open-Label Dose Confirmation and Dosimetry Study of Interstitial 131I-chTNT-1/B mAb (Cotara®) for the Treatment of Recurrent Glioblastoma Multiforme |
 |
Charleston, SC USA |
 |
08/26/2007 |
 |
 |
 |
 |
 |
Details |
 |
Open-Label Dose Confirmation and Dosimetry Study of Interstitial 131I-chTNT-1/B mAb (Cotara®) for the Treatment of Recurrent Glioblastoma Multiforme |
 |
Philadelphia, PA USA |
 |
08/26/2007 |
 |
 |
 |
Details |
 |
A Phase II Pilot Trial of Radiation Therapy With Concurrent and Adjuvant Temozolomide, Tamoxifen and Carboplatin (T2C) in the Treatment of Patients With Primary Central Nervous System Malignant Gliomas |
 |
Vista, CA USA |
 |
08/20/2007 |
 |
 |
 |
 |
 |
Details |
 |
Phase I/II Study of ZD6474 (ZactimaTM) With Radiation Therapy and Concomitant and Adjuvant Temozolomide in Patients With Newly-Diagnosed Glioblastoma |
 |
Boston, MA USA |
 |
08/19/2007 |
 |
 |
 |
Details |
 |
Phase I/II Study of ZD6474 (ZactimaTM) With Radiation Therapy and Concomitant and Adjuvant Temozolomide in Patients With Newly-Diagnosed Glioblastoma |
 |
Los Angeles, CA USA |
 |
08/19/2007 |
 |
 |
 |
 |
 |
Details |
 |
Phase I/II Study of ZD6474 (ZactimaTM) With Radiation Therapy and Concomitant and Adjuvant Temozolomide in Patients With Newly-Diagnosed Glioblastoma |
 |
Boston, MA USA |
 |
08/19/2007 |
 |
 |
 |
Details |
 |
Phase I/II Study of ZD6474 (ZactimaTM) With Radiation Therapy and Concomitant and Adjuvant Temozolomide in Patients With Newly-Diagnosed Glioblastoma |
 |
Boston, MA |
 |
08/19/2007 |
 |
 |
 |
 |
 |
Details |
 |
Phase I/II Study of ZD6474 (ZactimaTM) With Radiation Therapy and Concomitant and Adjuvant Temozolomide in Patients With Newly-Diagnosed Glioblastoma |
 |
New York, NY USA |
 |
08/19/2007 |
 |
 |
 |
Details |
 |
Gliadel and Dendritic Cell Vaccine for Malignant Glioma |
 |
Los Angeles, CA USA |
 |
08/18/2007 |
 |
 |
 |
 |
 |
Details |
 |
A Phase II Trial of Dendritic Cell Vaccine Pulsed with Tumor Lysate Followed by Temozolomide Upon Recurrence in Patients with Newly Diagnosed Glioblastoma |
 |
Los Angeles, CA USA |
 |
08/18/2007 |
 |
 |
 |
Details |
 |
Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor |
 |
Atlanta, GA USA |
 |
08/18/2007 |
 |
 |
 |
 |
 |
Details |
 |
Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor |
 |
Washington, DC USA |
 |
08/18/2007 |
 |
 |
 |
Details |
 |
Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor |
 |
Orange, CA USA |
 |
08/18/2007 |
 |
 |
 |
 |
 |
Details |
 |
Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor |
 |
St. Petersburg, FL USA |
 |
08/18/2007 |
 |
 |
 |
Details |
 |
Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor |
 |
West Palm Beach, FL USA |
 |
08/18/2007 |
 |
 |
 |
 |
 |
Details |
 |
Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor |
 |
Kansas City, MO USA |
 |
08/18/2007 |
 |
 |
 |
Details |
 |
Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor |
 |
Paterson, NJ USA |
 |
08/18/2007 |
 |
 |
 |
 |
 |
Details |
 |
Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor |
 |
Summit, NJ USA |
 |
08/18/2007 |
 |
 |
 |
Details |
 |
Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor |
 |
New York, NY USA |
 |
08/18/2007 |
 |
 |
 |
 |
 |
Details |
 |
Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor |
 |
Columbus, OH USA |
 |
08/18/2007 |
 |
 |
 |
Details |
 |
Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor |
 |
Roanoke, VA USA |
 |
08/18/2007 |
 |
 |
 |
 |
 |
Details |
 |
Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor |
 |
Perth, Western Australia, 6001, Australia |
 |
08/18/2007 |
 |
 |
 |
Details |
 |
Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor |
 |
Hamilton, Canada |
 |
08/18/2007 |
 |
 |
 |
 |
 |
Details |
 |
Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor |
 |
Charleston, WV USA |
 |
08/18/2007 |
 |
 |
 |
Details |
 |
Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor |
 |
San Antonio, TX USA |
 |
08/18/2007 |
 |
 |
 |
 |
 |
Details |
 |
Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor |
 |
Sacramento, CA USA |
 |
08/18/2007 |
 |
 |
 |
Details |
 |
Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor |
 |
Pittsburgh, PA USA |
 |
08/18/2007 |
 |
 |
 |
 |
 |
Details |
 |
Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor |
 |
Indianapolis, IN USA |
 |
08/18/2007 |
 |
 |
 |
Details |
 |
Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor |
 |
Charlotte, NC USA |
 |
08/18/2007 |
 |
 |
 |
 |
 |
Details |
 |
Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor |
 |
Oklahoma City, OK USA |
 |
08/18/2007 |
 |
 |
 |
Details |
 |
The use of the Gliasite radiation therapy system for malignant gliomas |
 |
Philadelphi, PA USA |
 |
08/18/2007 |
 |
 |
 |
 |
 |
Details |
 |
Stereotactic Radiosurgery for Metastatic Brain Tumors |
 |
Hackensack, NJ USA |
 |
08/18/2007 |
 |
 |
 |
Details |
 |
Phase 1 Trial Gamma Knife For Primary Brain Tumors - Gliomas. |
 |
Birmingham, AL USA |
 |
08/18/2007 |
 |
 |
 |
 |
 |
Details |
 |
A Phase I Imaging and Safety Study of Intravenous 131-I-TM-601 Labelled Chlorotoxin In Patients with Recurrent or Refractory Somatic and/or Cereberal Metastatic Solid Tumors |
 |
Chicago, IL USA |
 |
06/04/2007 |
 |
 |
 |
Details |
 |
A Phase I Imaging and Safety Study of Intravenous 131-I-TM-601 Labelled Chlorotoxin In Patients with Recurrent or Refractory Somatic and/or Cereberal Metastatic Solid Tumors |
 |
Birmingham, AL USA |
 |
06/04/2007 |
 |
 |
 |
 |
 |
Details |
 |
A Phase I Imaging and Safety Study of Intravenous 131-I-TM-601 Labelled Chlorotoxin In Patients with Recurrent or Refractory Somatic and/or Cereberal Metastatic Solid Tumors |
 |
Cambridge, MA USA |
 |
06/04/2007 |
 |
 |
 |
Details |
 |
A Phase I Imaging and Safety Study of Intravenous 131-I-TM-601 Labelled Chlorotoxin In Patients with Recurrent or Refractory Somatic and/or Cereberal Metastatic Solid Tumors |
 |
Grand Rapids, MI USA |
 |
06/04/2007 |
 |
 |
 |
 |
 |
Details |
 |
A Phase I Imaging and Safety Study of Intravenous 131-I-TM-601 Labelled Chlorotoxin In Patients with Recurrent or Refractory Somatic and/or Cereberal Metastatic Solid Tumors |
 |
Dallas, TX USA |
 |
06/04/2007 |
 |
 |
 |
Details |
 |
A Phase I/II Study Utilizing the Zeiss INTRABEAM System for the Treatment of a Resected Solitary Brain Metastasis |
 |
Cleveland, OH USA |
 |
05/01/2007 |
 |
 |
 |
 |
 |
Details |
 |
A Pilot Study of Temozolomide and 06Benzylguanine for Treatment of Newly Diagnosed High Grade Glioma, Using Autologous Peripheral Blood Stem Cells Genetically Modified for Chemoprotection |
 |
Cincinnati , OH USA |
 |
05/01/2007 |
 |
 |
 |
Details |
 |
Phase II Study of Brachytherapy Using the Intracavity GliaSite® Radiation Therapy System (RTS) With or Without Stereotactic Radiosurgery in Patients With Newly Diagnosed Supratentorial Brain Metastases |
 |
Chapel Hill, NC USA |
 |
05/01/2007 |
 |
 |
 |
 |
 |
Details |
 |
Phase II Study of Brachytherapy Using the Intracavity GliaSite® Radiation Therapy System (RTS) With or Without Stereotactic Radiosurgery in Patients With Newly Diagnosed Supratentorial Brain Metastases |
 |
Cleveland, OH USA |
 |
05/01/2007 |
 |
 |
 |
Details |
 |
Phase III Randomized Study of Radiotherapy Combined With Temozolomide Versus Carmustine in Patients With Anaplastic Astrocytoma or Mixed Gliomas
|
 |
Boston, MA USA |
 |
05/01/2007 |
 |
 |
 |
 |
 |
Details |
 |
Phase III Randomized Study of Radiotherapy Combined With Temozolomide Versus Carmustine in Patients With Anaplastic Astrocytoma or Mixed Gliomas
|
 |
Cleveland, OH USA |
 |
05/01/2007 |
 |
 |
 |
Details |
 |
Phase III Randomized Study of Radiotherapy Combined With Temozolomide Versus Carmustine in Patients With Anaplastic Astrocytoma or Mixed Gliomas
|
 |
Rochester, MN USA |
 |
05/01/2007 |
 |
 |
 |
 |
 |
Details |
 |
Phase III Randomized Study of Radiotherapy Combined With Temozolomide Versus Carmustine in Patients With Anaplastic Astrocytoma or Mixed Gliomas
|
 |
Jacksonville, FL USA |
 |
05/01/2007 |
 |
 |
 |
Details |
 |
Cilengitide and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme |
 |
Tampa, FL USA |
 |
05/01/2007 |
 |
 |
 |
 |
 |
Details |
 |
Cilengitide and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme |
 |
Winston-Salem, NC USA |
 |
05/01/2007 |
 |
 |
 |
Details |
 |
Cilengitide and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme |
 |
Boston, MA USA |
 |
05/01/2007 |
 |
 |
 |
 |
 |
Details |
 |
Cilengitide and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme |
 |
Detroit, MI USA |
 |
05/01/2007 |
 |
 |
 |
Details |
 |
Cilengitide and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme |
 |
Baltimore, MD USA |
 |
05/01/2007 |
 |
 |
 |
 |
 |
Details |
 |
Cilengitide and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme |
 |
Cleveland, OH USA |
 |
05/01/2007 |
 |
 |
 |
Details |
 |
Cilengitide and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme |
 |
Birmingham, AL USA |
 |
05/01/2007 |
 |
 |
 |
 |
 |
Details |
 |
Cilengitide and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme |
 |
Philadelphia, PA USA |
 |
05/01/2007 |
 |
 |
 |
Details |
 |
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas |
 |
Detroit, MI USA |
 |
05/01/2007 |
 |
 |
 |
 |
 |
Details |
 |
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas |
 |
Madison, WI USA |
 |
05/01/2007 |
 |
 |
 |
Details |
 |
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas |
 |
Cleveland, OH |
 |
05/01/2007 |
 |
 |
 |
 |
 |
Details |
 |
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas |
 |
Phoenix, AZ USA |
 |
05/01/2007 |
 |
 |
 |
Details |
 |
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas |
 |
New Haven, CT USA |
 |
05/01/2007 |
 |
 |
 |
 |
 |
Details |
 |
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas |
 |
Springfield, MO USA |
 |
05/01/2007 |
 |
 |
 |
Details |
 |
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas |
 |
Goldsboro, NC USA |
 |
05/01/2007 |
 |
 |
 |
 |
 |
Details |
 |
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas |
 |
, OH USA |
 |
05/01/2007 |
 |
 |
 |
Details |
 |
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas |
 |
Portland, OR USA |
 |
05/01/2007 |
 |
 |
 |
 |
 |
Details |
 |
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas |
 |
Greenville, SC USA |
 |
05/01/2007 |
 |
 |
 |
Details |
 |
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas |
 |
Rochester, MN USA |
 |
05/01/2007 |
 |
 |
 |
 |
 |
Details |
 |
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas |
 |
Philadelphia, PA USA |
 |
05/01/2007 |
 |
 |
 |
Details |
 |
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas |
 |
Kalamazoo, MI USA |
 |
05/01/2007 |
 |
 |
 |
 |
 |
Details |
 |
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas |
 |
Lambertville, MI USA |
 |
05/01/2007 |
 |
 |
 |
Details |
 |
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas |
 |
Saint Louis Park, MN USA |
 |
05/01/2007 |
 |
 |
 |
 |
 |
Details |
 |
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas |
 |
Lewes, DE USA |
 |
05/01/2007 |
 |
 |
 |
Details |
 |
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas |
 |
Columbus, GA USA |
 |
05/01/2007 |
 |
 |
 |
 |
 |
Details |
 |
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas |
 |
Dubuque, IA USA |
 |
05/01/2007 |
 |
 |
 |
Details |
 |
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas |
 |
Omaha, NB USA |
 |
05/01/2007 |
 |
 |
 |
 |
 |
Details |
 |
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas |
 |
Lebanon, NH USA |
 |
05/01/2007 |
 |
 |
 |
Details |
 |
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas |
 |
Albuquerque, NM USA |
 |
05/01/2007 |
 |
 |
 |
 |
 |
Details |
 |
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas |
 |
Buffalo, NY USA |
 |
05/01/2007 |
 |
 |
 |
Details |
 |
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas |
 |
Akron, OH USA |
 |
05/01/2007 |
 |
 |
 |
 |
 |
Details |
 |
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas |
 |
Tulsa, OK USA |
 |
05/01/2007 |
 |
 |
 |
Details |
 |
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas |
 |
Wynnewood, PA USA |
 |
05/01/2007 |
 |
 |
 |
 |
 |
Details |
 |
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas |
 |
Kingsport, TN USA |
 |
05/01/2007 |
 |
 |
 |
Details |
 |
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas |
 |
Salt Lake City, UT USA |
 |
05/01/2007 |
 |
 |
 |
 |
 |
Details |
 |
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas |
 |
Jacksonville, FL USA |
 |
05/01/2007 |
 |
 |
 |
Details |
 |
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas |
 |
Fort Lauderdale, FL USA |
 |
05/01/2007 |
 |
 |
 |
 |
 |
Details |
 |
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas |
 |
Miami, FL USA |
 |
05/01/2007 |
 |
 |
 |
Details |
 |
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas |
 |
Long Branch, NJ USA |
 |
05/01/2007 |
 |
 |
 |
 |
 |
Details |
 |
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas |
 |
Mount Holly, NJ USA |
 |
05/01/2007 |
 |
 |
 |
Details |
 |
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas |
 |
Utica, NY USA |
 |
05/01/2007 |
 |
 |
 |
 |
 |
Details |
 |
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas |
 |
Philadelphia, PA USA |
 |
05/01/2007 |
 |
 |
 |
Details |
 |
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas |
 |
Rochester, MN USA |
 |
05/01/2007 |
 |
 |
 |
 |
 |
Details |
 |
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas |
 |
Jacksonville, FL USA |
 |
05/01/2007 |
 |
 |
 |
Details |
 |
Radiation Therapy and Stereotactic Radiosurgery With or Without Temozolomide or Erlotinib in Treating Patients With Brain Metastases Secondary to Non-Small Cell Lung Cancer |
 |
Cleveland, OH |
 |
05/01/2007 |
 |
 |
 |
 |
 |
Details |
 |
Radiation Therapy and Stereotactic Radiosurgery With or Without Temozolomide or Erlotinib in Treating Patients With Brain Metastases Secondary to Non-Small Cell Lung Cancer |
 |
Phoenix, AZ USA |
 |
05/01/2007 |
 |
 |
 |
Details |
 |
Radiation Therapy and Stereotactic Radiosurgery With or Without Temozolomide or Erlotinib in Treating Patients With Brain Metastases Secondary to Non-Small Cell Lung Cancer |
 |
Kalamazoo, MI USA |
 |
05/01/2007 |
 |
 |
 |
 |
 |
Details |
 |
Radiation Therapy and Stereotactic Radiosurgery With or Without Temozolomide or Erlotinib in Treating Patients With Brain Metastases Secondary to Non-Small Cell Lung Cancer |
 |
Saint Louis Park, MN USA |
 |
05/01/2007 |
 |
 |
 |
Details |
 |
Radiation Therapy and Stereotactic Radiosurgery With or Without Temozolomide or Erlotinib in Treating Patients With Brain Metastases Secondary to Non-Small Cell Lung Cancer |
 |
Columbus, GA USA |
 |
05/01/2007 |
 |
 |
 |
 |
 |
Details |
 |
Radiation Therapy and Stereotactic Radiosurgery With or Without Temozolomide or Erlotinib in Treating Patients With Brain Metastases Secondary to Non-Small Cell Lung Cancer |
 |
Dubuque, IA USA |
 |
05/01/2007 |
 |
 |
 |
Details |
 |
Radiation Therapy and Stereotactic Radiosurgery With or Without Temozolomide or Erlotinib in Treating Patients With Brain Metastases Secondary to Non-Small Cell Lung Cancer |
 |
Akron, OH USA |
 |
05/01/2007 |
 |
 |
 |
 |
 |
Details |
 |
Radiation Therapy and Stereotactic Radiosurgery With or Without Temozolomide or Erlotinib in Treating Patients With Brain Metastases Secondary to Non-Small Cell Lung Cancer |
 |
Salt Lake City, UT USA |
 |
05/01/2007 |
 |
 |
 |
Details |
 |
Radiation Therapy and Stereotactic Radiosurgery With or Without Temozolomide or Erlotinib in Treating Patients With Brain Metastases Secondary to Non-Small Cell Lung Cancer |
 |
Manhasset, NY USA |
 |
05/01/2007 |
 |
 |
 |
 |
 |
Details |
 |
Radiation Therapy and Stereotactic Radiosurgery With or Without Temozolomide or Erlotinib in Treating Patients With Brain Metastases Secondary to Non-Small Cell Lung Cancer |
 |
Newark, DE USA |
 |
05/01/2007 |
 |
 |
 |
Details |
 |
Radiation Therapy and Stereotactic Radiosurgery With or Without Temozolomide or Erlotinib in Treating Patients With Brain Metastases Secondary to Non-Small Cell Lung Cancer |
 |
Orlando, FL USA |
 |
05/01/2007 |
 |
 |
 |
 |
 |
Details |
 |
Radiation Therapy and Stereotactic Radiosurgery With or Without Temozolomide or Erlotinib in Treating Patients With Brain Metastases Secondary to Non-Small Cell Lung Cancer |
 |
Boise, ID USA |
 |
05/01/2007 |
 |
 |
 |
Details |
 |
Radiation Therapy and Stereotactic Radiosurgery With or Without Temozolomide or Erlotinib in Treating Patients With Brain Metastases Secondary to Non-Small Cell Lung Cancer |
 |
Harvey, IL USA |
 |
05/01/2007 |
 |
 |
 |
 |
 |
Details |
 |
Radiation Therapy and Stereotactic Radiosurgery With or Without Temozolomide or Erlotinib in Treating Patients With Brain Metastases Secondary to Non-Small Cell Lung Cancer |
 |
Hammond, IN USA |
 |
05/01/2007 |
 |
 |
 |
Details |
 |
Radiation Therapy and Stereotactic Radiosurgery With or Without Temozolomide or Erlotinib in Treating Patients With Brain Metastases Secondary to Non-Small Cell Lung Cancer |
 |
Las Vegas, NV USA |
 |
05/01/2007 |
 |
 |
 |
 |
 |
Details |
 |
Radiation Therapy and Stereotactic Radiosurgery With or Without Temozolomide or Erlotinib in Treating Patients With Brain Metastases Secondary to Non-Small Cell Lung Cancer |
 |
Philadelphia, PA USA |
 |
05/01/2007 |
 |
 |
 |
Details |
 |
Radiation Therapy and Stereotactic Radiosurgery With or Without Temozolomide or Erlotinib in Treating Patients With Brain Metastases Secondary to Non-Small Cell Lung Cancer |
 |
Richmond, VA USA |
 |
05/01/2007 |
 |
 |
 |
 |
 |
Details |
 |
Radiation Therapy and Stereotactic Radiosurgery With or Without Temozolomide or Erlotinib in Treating Patients With Brain Metastases Secondary to Non-Small Cell Lung Cancer |
 |
Milwaukee, WI USA |
 |
05/01/2007 |
 |
 |
 |
Details |
 |
Talampanel, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
|
 |
Tampa, FL USA |
 |
04/29/2007 |
 |
 |
 |
 |
 |
Details |
 |
Talampanel, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
|
 |
Winston-Salem, NC USA |
 |
04/29/2007 |
 |
 |
 |
Details |
 |
Talampanel, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
|
 |
Boston, MA USA |
 |
04/29/2007 |
 |
 |
 |
 |
 |
Details |
 |
Talampanel, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
|
 |
Baltimore, MD USA |
 |
04/29/2007 |
 |
 |
 |
Details |
 |
Talampanel, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
|
 |
Atlanta, GA USA |
 |
04/29/2007 |
 |
 |
 |
 |
 |
Details |
 |
Talampanel, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
|
 |
Birmingham, AL USA |
 |
04/29/2007 |
 |
 |
 |
Details |
 |
Talampanel, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
|
 |
Philadelphia, PA USA |
 |
04/29/2007 |
 |
 |
 |
 |
 |
Details |
 |
Talampanel, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
|
 |
Detroit, MI USA |
 |
04/29/2007 |
 |
 |
 |
Details |
 |
Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas |
 |
Birmingham, AL USA |
 |
04/29/2007 |
 |
 |
 |
 |
 |
Details |
 |
Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas |
 |
Phoenix, AZ USA |
 |
04/29/2007 |
 |
 |
 |
Details |
 |
Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas |
 |
Cleveland, OH USA |
 |
04/29/2007 |
 |
 |
 |
 |
 |
Details |
 |
Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas |
 |
Phoenix, AZ USA |
 |
04/29/2007 |
 |
 |
 |
Details |
 |
Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas |
 |
Los Angeles, CA USA |
 |
04/29/2007 |
 |
 |
 |
 |
 |
Details |
 |
Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas |
 |
Long Beach, CA USA |
 |
04/29/2007 |
 |
 |
 |
Details |
 |
Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas |
 |
Sacramento, CA USA |
 |
04/29/2007 |
 |
 |
 |
 |
 |
Details |
 |
Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas |
 |
St. Petersburg, FL USA |
 |
04/29/2007 |
 |
 |
 |
Details |
 |
Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas |
 |
Jacksonville, FL USA |
 |
04/29/2007 |
 |
 |
 |
 |
 |
Details |
 |
Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas |
 |
West Palm Beach, FL USA |
 |
04/29/2007 |
 |
 |
 |
Details |
 |
Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas |
 |
Augusta, GA USA |
 |
04/29/2007 |
 |
 |
 |
 |
 |
Details |
 |
Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas |
 |
Honolulu, HI USA |
 |
04/29/2007 |
 |
 |
 |
Details |
 |
Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas |
 |
Chicago, IL USA |
 |
04/29/2007 |
 |
 |
 |
 |
 |
Details |
 |
Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas |
 |
Park Ridge, IL USA |
 |
04/29/2007 |
 |
 |
 |
Details |
 |
Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas |
 |
Iowa City, IA USA |
 |
04/29/2007 |
 |
 |
 |
 |
 |
Details |
 |
Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas |
 |
Scarborough, ME USA |
 |
04/29/2007 |
 |
 |
 |
Details |
 |
Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas |
 |
Baltimore, MD USA |
 |
04/29/2007 |
 |
 |
 |
 |
 |
Details |
 |
Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas |
 |
Boston, MA USA |
 |
04/29/2007 |
 |
 |
 |
Details |
 |
Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas |
 |
Grand Rapids, MI USA |
 |
04/29/2007 |
 |
 |
 |
 |
 |
Details |
 |
Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas |
 |
Saint Louis, MO USA |
 |
04/29/2007 |
 |
 |
 |
Details |
 |
Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas |
 |
Kansas City, MO USA |
 |
04/29/2007 |
 |
 |
 |
 |
 |
Details |
 |
Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas |
 |
Saint Louis, MO USA |
 |
04/29/2007 |
 |
 |
 |
Details |
 |
Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas |
 |
Omaha, NE USA |
 |
04/29/2007 |
 |
 |
 |
 |
 |
Details |
 |
Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas |
 |
Las Vegas, NV USA |
 |
04/29/2007 |
 |
 |
 |
Details |
 |
Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas |
 |
Hackensack, NJ USA |
 |
04/29/2007 |
 |
 |
 |
 |
 |
Details |
 |
Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas |
 |
Summit, NJ USA |
 |
04/29/2007 |
 |
 |
 |
Details |
 |
Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas |
 |
Brooklyn, NY USA |
 |
04/29/2007 |
 |
 |
 |
 |
 |
Details |
 |
Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas |
 |
Rochester, NY USA |
 |
04/29/2007 |
 |
 |
 |
Details |
 |
Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas |
 |
New York, NY USA |
 |
04/29/2007 |
 |
 |
 |
 |
 |
Details |
 |
Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas |
 |
Valhalla, NY USA |
 |
04/29/2007 |
 |
 |
 |
Details |
 |
Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas |
 |
New Hyde Park, NY USA |
 |
04/29/2007 |
 |
 |
 |
 |
 |
Details |
 |
Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas |
 |
Dayton, OH USA |
 |
04/29/2007 |
 |
 |
 |
Details |
 |
Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas |
 |
Cleveland, OH USA |
 |
04/29/2007 |
 |
 |
 |
 |
 |
Details |
 |
Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas |
 |
Knoxville, TN USA |
 |
04/29/2007 |
 |
 |
 |
Details |
 |
Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas |
 |
Memphis, TN USA |
 |
04/29/2007 |
 |
 |
 |
 |
 |
Details |
 |
Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas |
 |
Houston, TX USA |
 |
04/29/2007 |
 |
 |
 |
Details |
 |
Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas |
 |
Fort Worth, TX USA |
 |
04/29/2007 |
 |
 |
 |
 |
 |
Details |
 |
Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas |
 |
Lubbock, TX USA |
 |
04/29/2007 |
 |
 |
 |
Details |
 |
Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas |
 |
Dallas, TX USA |
 |
04/29/2007 |
 |
 |
 |
 |
 |
Details |
 |
Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas |
 |
San Antonio, TX USA |
 |
04/29/2007 |
 |
 |
 |
Details |
 |
Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas |
 |
Burlington, VT USA |
 |
04/29/2007 |
 |
 |
 |
 |
 |
Details |
 |
Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas |
 |
Roanoke, VA USA |
 |
04/29/2007 |
 |
 |
 |
Details |
 |
Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas |
 |
Falls Church, VA USA |
 |
04/29/2007 |
 |
 |
 |
 |
 |
Details |
 |
Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas |
 |
Huntington, WV USA |
 |
04/29/2007 |
 |
 |
 |
Details |
 |
Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas |
 |
Milwaukee, WI USA |
 |
04/29/2007 |
 |
 |
 |
 |
 |
Details |
 |
Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas |
 |
Downey, CA USA |
 |
04/29/2007 |
 |
 |
 |
Details |
 |
Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas |
 |
Atlanta, GA USA |
 |
04/29/2007 |
 |
 |
 |
 |
 |
Details |
 |
Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas |
 |
Denver, CO USA |
 |
04/29/2007 |
 |
 |
 |
Details |
 |
Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas |
 |
Pittsburgh, PA USA |
 |
04/29/2007 |
 |
 |
 |
 |
 |
Details |
 |
Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas |
 |
New Orleans, LA USA |
 |
04/29/2007 |
 |
 |
 |
Details |
 |
A Randomized, Open-Label Phase 3 Study of Temozolomide Added to Whole Brain Radiation Therapy Versus Whole Brain Radiation Therapy Alone for the Treatment of Brain Metastasis From Non-Small Cell Lung Cancer |
 |
Los Angeles, CA USA |
 |
04/27/2007 |
 |
 |
 |
 |
 |
Details |
 |
Safety Study of Tarceva in Children With Refractory and Relapsed Malignant Brain Tumors and Newly Diagnosed Brain Stem Glioma |
 |
Villejuif, France |
 |
04/15/2007 |
 |
 |
 |
Details |
 |
Erlotinib (Tarceva) Alone or in Combination With Radiation Therapy in Treating Young Patients With Refractory or Relapsed Malignant Brain Tumors or Newly Diagnosed Brain Stem Glioma |
 |
Dublin, USA |
 |
04/15/2007 |
 |
 |
 |
 |
 |
Details |
 |
A Phase 2 Multicenter Study of AQ4N in Combination With Radiotherapy and Temozolomide, for Safety, Tolerability, and Activity in Subjects With Newly Diagnosed Glioblastoma Multiforme |
 |
Detroit, MI USA |
 |
11/05/2006 |
 |
 |
 |
Details |
 |
Phase I Study of Temsirolimus and Concurrent Chemoradiotherapy Comprising Temozolomide and Radiotherapy Followed By Adjuvant Temsirolimus and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme
|
 |
Des Moines, IA USA |
 |
08/11/2006 |
 |
 |
 |
 |
 |
Details |
 |
Phase I Study of Temsirolimus and Concurrent Chemoradiotherapy Comprising Temozolomide and Radiotherapy Followed By Adjuvant Temsirolimus and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme
|
 |
Jacksonville, FL USA |
 |
08/11/2006 |
 |
 |
 |
Details |
 |
Phase I Study of Temsirolimus and Concurrent Chemoradiotherapy Comprising Temozolomide and Radiotherapy Followed By Adjuvant Temsirolimus and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme
|
 |
Scottsdale/Phoenix, AZ USA |
 |
08/11/2006 |
 |
 |
 |
 |
 |
Details |
 |
Erlotinib and Temozolomide With Radiation Therapy in Treating Patients With Glioblastoma Multiforme or Other Brain Tumors |
 |
Wichita, KS USA |
 |
06/26/2006 |
 |
 |
 |
Details |
 |
Erlotinib and Temozolomide With Radiation Therapy in Treating Patients With Glioblastoma Multiforme or Other Brain Tumors |
 |
Urbana, IL USA |
 |
06/26/2006 |
 |
 |
 |
 |
 |
Details |
 |
Erlotinib and Temozolomide With Radiation Therapy in Treating Patients With Glioblastoma Multiforme or Other Brain Tumors |
 |
Peoria, IL USA |
 |
06/26/2006 |
 |
 |
 |
Details |
 |
Erlotinib and Temozolomide With Radiation Therapy in Treating Patients With Glioblastoma Multiforme or Other Brain Tumors |
 |
Cedar Rapids, IA USA |
 |
06/26/2006 |
 |
 |
 |
 |
 |
Details |
 |
Erlotinib and Temozolomide With Radiation Therapy in Treating Patients With Glioblastoma Multiforme or Other Brain Tumors |
 |
Des Moines, IA USA |
 |
06/26/2006 |
 |
 |
 |
Details |
 |
Erlotinib and Temozolomide With Radiation Therapy in Treating Patients With Glioblastoma Multiforme or Other Brain Tumors |
 |
Sioux City, IA USA |
 |
06/26/2006 |
 |
 |
 |
 |
 |
Details |
 |
Erlotinib and Temozolomide With Radiation Therapy in Treating Patients With Glioblastoma Multiforme or Other Brain Tumors |
 |
Saint Cloud, MN USA |
 |
06/26/2006 |
 |
 |
 |
Details |
 |
Erlotinib and Temozolomide With Radiation Therapy in Treating Patients With Glioblastoma Multiforme or Other Brain Tumors |
 |
Fargo, ND USA |
 |
06/26/2006 |
 |
 |
 |
 |
 |
Details |
 |
Erlotinib and Temozolomide With Radiation Therapy in Treating Patients With Glioblastoma Multiforme or Other Brain Tumors |
 |
Birmingham, AL USA |
 |
06/26/2006 |
 |
 |
 |
Details |
 |
Erlotinib and Temozolomide With Radiation Therapy in Treating Patients With Glioblastoma Multiforme or Other Brain Tumors |
 |
Moline, IL USA |
 |
06/26/2006 |
 |
 |
 |
 |
 |
Details |
 |
Erlotinib and Temozolomide With Radiation Therapy in Treating Patients With Glioblastoma Multiforme or Other Brain Tumors |
 |
Missouri Valley, IA USA |
 |
06/26/2006 |
 |
 |
 |
Details |
 |
Erlotinib and Temozolomide With Radiation Therapy in Treating Patients With Glioblastoma Multiforme or Other Brain Tumors |
 |
Lincoln, NE USA |
 |
06/26/2006 |
 |
 |
 |
 |
 |
Details |
 |
Erlotinib and Temozolomide With Radiation Therapy in Treating Patients With Glioblastoma Multiforme or Other Brain Tumors |
 |
Bismarck, ND USA |
 |
06/26/2006 |
 |
 |
 |
Details |
 |
Erlotinib and Temozolomide With Radiation Therapy in Treating Patients With Glioblastoma Multiforme or Other Brain Tumors |
 |
Allentown, PA USA |
 |
06/26/2006 |
 |
 |
 |
 |
 |
Details |
 |
Erlotinib and Temozolomide With Radiation Therapy in Treating Patients With Glioblastoma Multiforme or Other Brain Tumors |
 |
Rochester, MN USA |
 |
06/26/2006 |
 |
 |
 |
Details |
 |
Erlotinib and Temozolomide With Radiation Therapy in Treating Patients With Glioblastoma Multiforme or Other Brain Tumors |
 |
Jacksonville, FL USA |
 |
06/26/2006 |
 |
 |
 |
 |
 |
Details |
 |
Erlotinib and Temozolomide With Radiation Therapy in Treating Patients With Glioblastoma Multiforme or Other Brain Tumors |
 |
Scottsdale/Phoenix, AZ USA |
 |
06/26/2006 |
 |
 |
 |
Details |
 |
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
 |
Little Rock, AR USA |
 |
05/30/2006 |
 |
 |
 |
 |
 |
Details |
 |
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
 |
Jacksonville, FL USA |
 |
05/30/2006 |
 |
 |
 |
Details |
 |
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
 |
Honolulu, HI USA |
 |
05/30/2006 |
 |
 |
 |
 |
 |
Details |
 |
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
 |
Boise, ID USA |
 |
05/30/2006 |
 |
 |
 |
Details |
 |
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
 |
Chicago, IL USA |
 |
05/30/2006 |
 |
 |
 |
 |
 |
Details |
 |
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
 |
Peoria, IL USA |
 |
05/30/2006 |
 |
 |
 |
Details |
 |
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
 |
Boston, MA USA |
 |
05/30/2006 |
 |
 |
 |
 |
 |
Details |
 |
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
 |
Kalamazoo, MI USA |
 |
05/30/2006 |
 |
 |
 |
Details |
 |
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
 |
Grand Rapids, MI USA |
 |
05/30/2006 |
 |
 |
 |
 |
 |
Details |
 |
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
 |
Kansas City, MO USA |
 |
05/30/2006 |
 |
 |
 |
Details |
 |
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
 |
Saint Louis, MO USA |
 |
05/30/2006 |
 |
 |
 |
 |
 |
Details |
 |
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
 |
Las Vegas, NV USA |
 |
05/30/2006 |
 |
 |
 |
Details |
 |
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
 |
Summit, NJ USA |
 |
05/30/2006 |
 |
 |
 |
 |
 |
Details |
 |
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
 |
New York, NY USA |
 |
05/30/2006 |
 |
 |
 |
Details |
 |
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
 |
Valhalla, NY USA |
 |
05/30/2006 |
 |
 |
 |
 |
 |
Details |
 |
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
 |
Dayton, OH USA |
 |
05/30/2006 |
 |
 |
 |
Details |
 |
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
 |
Columbus, OH USA |
 |
05/30/2006 |
 |
 |
 |
 |
 |
Details |
 |
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
 |
Cleveland, OH USA |
 |
05/30/2006 |
 |
 |
 |
Details |
 |
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
 |
Nashville, TN USA |
 |
05/30/2006 |
 |
 |
 |
 |
 |
Details |
 |
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
 |
Fort Worth, TX USA |
 |
05/30/2006 |
 |
 |
 |
Details |
 |
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
 |
Amarillo, TX USA |
 |
05/30/2006 |
 |
 |
 |
 |
 |
Details |
 |
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
 |
Huntington, WV USA |
 |
05/30/2006 |
 |
 |
 |
Details |
 |
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
 |
Perth, Western Australia, 6001, Australia |
 |
05/30/2006 |
 |
 |
 |
 |
 |
Details |
 |
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
 |
, Canada |
 |
05/30/2006 |
 |
 |
 |
Details |
 |
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
 |
, Canada |
 |
05/30/2006 |
 |
 |
 |
 |
 |
Details |
 |
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
 |
Charleston, WV USA |
 |
05/30/2006 |
 |
 |
 |
Details |
 |
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
 |
Downey, CA USA |
 |
05/30/2006 |
 |
 |
 |
 |
 |
Details |
 |
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
 |
Phoenix, AZ USA |
 |
05/30/2006 |
 |
 |
 |
Details |
 |
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
 |
Lebanon, NH USA |
 |
05/30/2006 |
 |
 |
 |
 |
 |
Details |
 |
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
 |
Charleston, SC USA |
 |
05/30/2006 |
 |
 |
 |
Details |
 |
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
 |
Pittsburgh, PA USA |
 |
05/30/2006 |
 |
 |
 |
 |
 |
Details |
 |
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
 |
Boston, MA USA |
 |
05/30/2006 |
 |
 |
 |
Details |
 |
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
 |
Farmington, CT USA |
 |
05/30/2006 |
 |
 |
 |
 |
 |
Details |
 |
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
 |
Orlando, FL USA |
 |
05/30/2006 |
 |
 |
 |
Details |
 |
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
 |
Pensacola, FL USA |
 |
05/30/2006 |
 |
 |
 |
 |
 |
Details |
 |
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
 |
Gainesville, FL USA |
 |
05/30/2006 |
 |
 |
 |
Details |
 |
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
 |
Miami, FL USA |
 |
05/30/2006 |
 |
 |
 |
 |
 |
Details |
 |
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
 |
Indianapolis, IN USA |
 |
05/30/2006 |
 |
 |
 |
Details |
 |
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
 |
Indianapolis, IN USA |
 |
05/30/2006 |
 |
 |
 |
 |
 |
Details |
 |
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
 |
Kansas City, KS USA |
 |
05/30/2006 |
 |
 |
 |
Details |
 |
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
 |
Louisville, KY USA |
 |
05/30/2006 |
 |
 |
 |
 |
 |
Details |
 |
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
 |
Bangor, ME USA |
 |
05/30/2006 |
 |
 |
 |
Details |
 |
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
 |
Detroit, MI USA |
 |
05/30/2006 |
 |
 |
 |
 |
 |
Details |
 |
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
 |
Rochester, MN USA |
 |
05/30/2006 |
 |
 |
 |
Details |
 |
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
 |
Jackson, MS USA |
 |
05/30/2006 |
 |
 |
 |
 |
 |
Details |
 |
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
 |
New Brunswick, NJ USA |
 |
05/30/2006 |
 |
 |
 |
Details |
 |
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
 |
Albuquerque, NM USA |
 |
05/30/2006 |
 |
 |
 |
 |
 |
Details |
 |
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
 |
Syracuse, NY USA |
 |
05/30/2006 |
 |
 |
 |
Details |
 |
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
 |
Charlotte, NC USA |
 |
05/30/2006 |
 |
 |
 |
 |
 |
Details |
 |
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
 |
Cincinnati,, OH USA |
 |
05/30/2006 |
 |
 |
 |
Details |
 |
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
 |
Oklahoma City, OK USA |
 |
05/30/2006 |
 |
 |
 |
 |
 |
Details |
 |
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
 |
Hershey, PA USA |
 |
05/30/2006 |
 |
 |
 |
Details |
 |
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
 |
Columbia, SC USA |
 |
05/30/2006 |
 |
 |
 |
 |
 |
Details |
 |
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
 |
Corpus Christi, TX USA |
 |
05/30/2006 |
 |
 |
 |
Details |
 |
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
 |
Dallas, TX USA |
 |
05/30/2006 |
 |
 |
 |
 |
 |
Details |
 |
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
 |
Salt Lake City, UT USA |
 |
05/30/2006 |
 |
 |
 |
Details |
 |
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
 |
Spokane, WA USA |
 |
05/30/2006 |
 |
 |
 |
 |
 |
Details |
 |
Phase I/II Study of Motexafin Gadolinium Given Concurrently With Temozolomide and Fractionated Radiotherapy in Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme |
 |
Phoenix, AZ USA |
 |
05/29/2006 |
 |
 |
 |
Details |
 |
Phase I/II Study of Motexafin Gadolinium Given Concurrently With Temozolomide and Fractionated Radiotherapy in Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme |
 |
Jacksonville, FL USA |
 |
05/29/2006 |
 |
 |
 |
 |
 |
Details |
 |
Phase I/II Study of Motexafin Gadolinium Given Concurrently With Temozolomide and Fractionated Radiotherapy in Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme |
 |
Akron, OH USA |
 |
05/29/2006 |
 |
 |
 |
Details |
 |
Phase I/II Study of Motexafin Gadolinium Given Concurrently With Temozolomide and Fractionated Radiotherapy in Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme |
 |
Murray, UT USA |
 |
05/29/2006 |
 |
 |
 |
 |
 |
Details |
 |
Phase I/II Study of Motexafin Gadolinium Given Concurrently With Temozolomide and Fractionated Radiotherapy in Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme |
 |
Saint George, UT USA |
 |
05/29/2006 |
 |
 |
 |
Details |
 |
Phase I/II Study of Motexafin Gadolinium Given Concurrently With Temozolomide and Fractionated Radiotherapy in Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme |
 |
Ogden, UT USA |
 |
05/29/2006 |
 |
 |
 |
 |
 |
Details |
 |
Phase I/II Study of Motexafin Gadolinium Given Concurrently With Temozolomide and Fractionated Radiotherapy in Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme |
 |
Provo, UT USA |
 |
05/29/2006 |
 |
 |
 |
Details |
 |
Phase I/II Study of Motexafin Gadolinium Given Concurrently With Temozolomide and Fractionated Radiotherapy in Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme |
 |
Kearney, NE USA |
 |
05/29/2006 |
 |
 |
 |
 |
 |
Details |
 |
Phase I/II Study of Motexafin Gadolinium Given Concurrently With Temozolomide and Fractionated Radiotherapy in Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme |
 |
Vineland, NJ USA |
 |
05/29/2006 |
 |
 |
 |
Details |
 |
Phase I/II Study of Motexafin Gadolinium Given Concurrently With Temozolomide and Fractionated Radiotherapy in Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme |
 |
Wheeling, WV USA |
 |
05/29/2006 |
 |
 |
 |
 |
 |
Details |
 |
A Phase II Study of Radiation With Concomitant and Then Sequential Temozolomide in Patients With Newly Diagnosed Supratentorial Malignant Glioma Who Have Undergone Surgery With Gliadel Wafer Insertion |
 |
Louisville, KY USA |
 |
05/27/2006 |
 |
 |
 |
Details |
 |
A Phase I Study of Tomotherapy in Patients With Benign Brain Tumour |
 |
Edmonton, Alberta, Canada |
 |
05/04/2006 |
 |
 |
 |
 |
 |
Details |
 |
Treatment of Primary Glioblastoma Multiforme With Cetuximab (Erbitux), Radiotherapy and Temozolomide (GERT) – Phase I/II Trial |
 |
Heidelberg, Baden-Württemberg, Germany |
 |
05/04/2006 |
 |
 |
 |
Details |
 |
Phase 3 study: Radiation Therapy and Combination Chemotherapy Followed by Autologous Stem Cell Transplant in Treating Patients With Newly Diagnosed Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Atypical Teratoid Rhabdoid Tumor |
 |
Durham, NC USA |
 |
05/02/2006 |
 |
 |
 |
 |
 |
Details |
 |
Phase 3 study: Radiation Therapy and Combination Chemotherapy Followed by Autologous Stem Cell Transplant in Treating Patients With Newly Diagnosed Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Atypical Teratoid Rhabdoid Tumor |
 |
Memphis, TN USA |
 |
05/02/2006 |
 |
 |
 |
Details |
 |
Phase 3 study: Radiation Therapy and Combination Chemotherapy Followed by Autologous Stem Cell Transplant in Treating Patients With Newly Diagnosed Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Atypical Teratoid Rhabdoid Tumor |
 |
Houston, TX USA |
 |
05/02/2006 |
 |
 |
 |
 |
 |
Details |
 |
Randomized Phase III Trial of Postoperative Whole Brain Radiation Therapy Compared With Salvage Stereotactic Radiosurgery in Patients With One to Four Brain Metastasis: Japan Clinical Oncology Group Study (JCOG 0504) |
 |
Yamagata, Japan |
 |
04/30/2006 |
 |
 |
 |
Details |
 |
Cilengitide and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme |
 |
Detroit, MI USA |
 |
02/03/2006 |
 |
 |
 |
 |
 |
Details |
 |
Iodine I 131 Monoclonal Antibody TNT-1/B (131I MOAB TNT-1/B), in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme |
 |
Detroit, MI USA |
 |
02/03/2006 |
 |
 |
 |
Details |
 |
Phase I/II Study of Concurrent Dose Escalation Temodar and Whole Brain Radiation Therapy in Patients with Multiple Brain Metastases.
|
 |
Detroit, MI USA |
 |
02/03/2006 |
 |
 |
 |
 |
 |
Details |
 |
Phase II Study Utilizing Focal Radiation in Patients with 1-3 Brain Metastases.
|
 |
Detroit, MI USA |
 |
02/03/2006 |
 |
 |
 |
Details |
 |
Boron Neutron Capture Therapy Following Surgery in Treating Patients With Glioblastoma Multiforme Removed During Surgery |
 |
, Austria |
 |
01/08/2006 |
 |
 |
 |
 |
 |
Details |
 |
Boron Neutron Capture Therapy Following Surgery in Treating Patients With Glioblastoma Multiforme Removed During Surgery |
 |
Toronto, Ontario, Canada |
 |
01/08/2006 |
 |
 |
 |
Details |
 |
Boron Neutron Capture Therapy Following Surgery in Treating Patients With Glioblastoma Multiforme Removed During Surgery |
 |
Nice, 06002, France |
 |
01/08/2006 |
 |
 |
 |
 |
 |
Details |
 |
Boron Neutron Capture Therapy Following Surgery in Treating Patients With Glioblastoma Multiforme Removed During Surgery |
 |
Munich, D-81377, Germany |
 |
01/08/2006 |
 |
 |
 |
Details |
 |
Boron Neutron Capture Therapy Following Surgery in Treating Patients With Glioblastoma Multiforme Removed During Surgery |
 |
Pisa, 56100, Italy |
 |
01/08/2006 |
 |
 |
 |
 |
 |
Details |
 |
Boron Neutron Capture Therapy Following Surgery in Treating Patients With Glioblastoma Multiforme Removed During Surgery |
 |
Petten, NL-1755 ZG, Netherlands |
 |
01/08/2006 |
 |
 |
 |
Details |
 |
Boron Neutron Capture Therapy Following Surgery in Treating Patients With Glioblastoma Multiforme Removed During Surgery |
 |
Amsterdam, 1007 MB, Netherlands |
 |
01/08/2006 |
 |
 |
 |
 |
 |
Details |
 |
Boron Neutron Capture Therapy Following Surgery in Treating Patients With Glioblastoma Multiforme Removed During Surgery |
 |
ESSEN, Germany |
 |
01/08/2006 |
 |
 |
 |
Details |
 |
Gamma Knife Radiosurgery |
 |
Edison, NJ USA |
 |
12/03/2005 |
 |
 |
 |
 |
 |
Details |
 |
Gamma Knife Radiosurgery |
 |
Smithtown, NY USA |
 |
12/03/2005 |
 |
 |
 |
Details |
 |
Fractionated Streotactic Rdaiotherapy boost and Temozolamide in malignant Gliomas |
 |
Brooklyn, NY USA |
 |
12/03/2005 |
 |
 |
 |
 |
 |
Details |
 |
Stereotactic Radiosurgery VS. Conventional Radiotherapy for Recurrent / Invasive Pituitary Tumors |
 |
Hackensack, NJ USA |
 |
12/03/2005 |
 |
 |
 |
Details |
 |
Treatment of newly diagnosed Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor (PNET), or Atypical Teratoid Rhabdoid Tumor (ATRT) |
 |
Memphis, TN USA |
 |
12/03/2005 |
 |
 |
 |
 |
 |
Details |
 |
Gamma Knife Radiosurgery for Brain Tumors |
 |
La Jolla, CA USA |
 |
12/03/2005 |
 |
 |
 |
Details |
 |
Fractionated Stereotactic Radiosurgery plus Topotecan radiation sensitizer in the treatment of recurrent malignant astrocytoma or as consolidation after external beam radiotherapy. |
 |
New York, NY USA |
 |
12/03/2005 |
 |
 |
 |
 |
 |
Details |
 |
Gamma knife stereotactic radiosurgery for benign and malignant brain tumors and brain metastases. |
 |
Rockville Centre, NY USA |
 |
12/03/2005 |
 |
 |
 |
Details |
 |
Pilot study of systemic and intrathecal chemotherapy followed by conformal radiation for infants with embryonal intracranial central nervous system tumors. |
 |
Durham, NC USA |
 |
12/03/2005 |
 |
 |
 |
 |
 |
Details |
 |
The use of the Gliasite radiation therapy system for malignant gliomas |
 |
Mobile , AL |
 |
12/03/2005 |
 |
 |
 |
Details |
 |
Fractionated stereotactic radiotherapy for the treatment of acoustic neuromas, meningiomas and metastatic brain tumors. |
 |
New York, NY USA |
 |
12/03/2005 |
 |
 |
 |
 |